Recent Advances in the Management of Patients with Relapsed/Refractory Follicular Lymphoma
{{output}}
Advanced follicular lymphoma (FL) often relapses after front-line chemoimmunotherapy, and many patients will eventually require subsequent therapy. In 2021, two new therapies were granted approval by the Food and Drug Administration (FDA), including the PI3Kδ... ...